Nifedipine
- Product NDC
- 70934-603
- 11-digit product format
- 709340603
- Labeler code
- 70934
- Product ID
- 70934-603_ab832140-eeab-4dd4-e053-2a95a90aacf7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nifedipine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA203126
- Marketing category
- ANDA
- Marketing start
- 2020-03-05
- Marketing end
- 0000-00-00
- Substance
- NIFEDIPINE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-603-30 | 70934060330 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-603-30) | 2020-03-05 | 0000-00-00 | No | No | Current |
| 70934-603-90 | 70934060390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-603-90) | 2020-05-26 | 0000-00-00 | No | No | Current |